A comprehensive search was performed in electronic databases including PubMed, the Cochrane Library, Embase for possible controlled studies. The primary outcomes were
stenosis rate and endoscopic balloon dilatation (EBD) sessions required, and secondary outcome included complications. Random effects were used to calculate the pooled outcome. Sensitivity analysis and publication bias were conducted to verify the robustness and reliability of the results. Results: Ten studies containing 499 patients were obtained. In the pooled analysis, statistical significance was found in
triamcinolone acetonide injection reduced the incidence of
stenosis (OR = 0.29, 95% CI [0.11, 0.80], P < 0.05) and the number of endoscopic balloon dilation (MD = -3.33, 95% CI [-4.15, -2.50], P < 0.0001) compared with control.
Triamcinolone acetonide injection
therapy did not increase the risk of complications (OR = -0.77%, CI [-1.62, 0.09], P = 0.08). Subgroup analysis indicated that the single injection of
triamcinolone acetonide after endoscopic submucosal dissection significantly reduced the incidence of
stenosis compared with without any prophylaxis. Different concentrations and single session volume of
triamcinolone acetonide reduced the incidence of
stenosis. It also showed that the dose according to the size of the lesion was more effective than the fixed dose in preventing
esophageal stricture. Conclusion:
Triamcinolone acetonide injection can reduce the incidence of
stricture formation as well as the need for EBD sessions without increasing complications.